Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ke Shuai

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Optics Letters|September 13, 2024
Ultra-smooth processing of lithium niobate for outstanding mid-infrared transmittanceKe-Shuai Tian, Hong-Yu Li, Zhen Wang, et al.
The Journal of Biological Chemistry|April 30, 2003
PIASx is a transcriptional co-repressor of signal transducer and activator of transcription 4Taruna Arora, Bin Liu, Hongchin He, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 15, 2018
miRNA-448 inhibits cell growth by targeting BCL-2 in hepatocellular carcinomaZhi-Bin Liao, Xiao-Long Tan, Ke-Shuai Dong, et al.
Molecular and Cellular Biology|January 20, 2005
Negative regulation of NF-kappaB signaling by PIAS1Bin Liu, Randy Yang, Kelly A Wong, et al.
Cell|April 9, 2008
Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalphaMeelad M Dawlaty, Liviu Malureanu, Karthik B Jeganathan, et al.
Oncogene|November 20, 2019
TGF-β1 accelerates the hepatitis B virus X-induced malignant transformation of hepatic progenitor cells by upregulating miR-199a-3pKe-Shuai Dong, Yan Chen, Guang Yang, et al.
The EMBO Journal|May 20, 2006
UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activityOxana A Malakhova, Keun Il Kim, Jiann-Kae Luo, et al.
Surgery|October 11, 2015
Severity of cirrhosis should determine the operative modality for patients with early hepatocellular carcinoma and compensated liver functionZhi-yong Huang, Bin-yong Liang, Min Xiong, et al.
Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban|July 31, 2015
Synergistic suppressive effect of PARP-1 inhibitor PJ34 and HDAC inhibitor SAHA on proliferation of liver cancer cellsBin-Yong Liang, Min Xiong, Gui-Bao Ji, et al.
Asian Journal of Surgery|February 21, 2019
Histologic severity of liver cirrhosis: A key factor affecting surgical outcomes of hepatocellular carcinoma in patients with portal hypertensionKe-Shuai Dong, Bin-Yong Liang, Zun-Yi Zhang, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Optics Letters|September 13, 2024
Ultra-smooth processing of lithium niobate for outstanding mid-infrared transmittanceKe-Shuai Tian, Hong-Yu Li, Zhen Wang, et al.
The Journal of Biological Chemistry|April 30, 2003
PIASx is a transcriptional co-repressor of signal transducer and activator of transcription 4Taruna Arora, Bin Liu, Hongchin He, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 15, 2018
miRNA-448 inhibits cell growth by targeting BCL-2 in hepatocellular carcinomaZhi-Bin Liao, Xiao-Long Tan, Ke-Shuai Dong, et al.
Molecular and Cellular Biology|January 20, 2005
Negative regulation of NF-kappaB signaling by PIAS1Bin Liu, Randy Yang, Kelly A Wong, et al.
Cell|April 9, 2008
Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalphaMeelad M Dawlaty, Liviu Malureanu, Karthik B Jeganathan, et al.
Oncogene|November 20, 2019
TGF-β1 accelerates the hepatitis B virus X-induced malignant transformation of hepatic progenitor cells by upregulating miR-199a-3pKe-Shuai Dong, Yan Chen, Guang Yang, et al.
The EMBO Journal|May 20, 2006
UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activityOxana A Malakhova, Keun Il Kim, Jiann-Kae Luo, et al.
Surgery|October 11, 2015
Severity of cirrhosis should determine the operative modality for patients with early hepatocellular carcinoma and compensated liver functionZhi-yong Huang, Bin-yong Liang, Min Xiong, et al.
Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban|July 31, 2015
Synergistic suppressive effect of PARP-1 inhibitor PJ34 and HDAC inhibitor SAHA on proliferation of liver cancer cellsBin-Yong Liang, Min Xiong, Gui-Bao Ji, et al.
Asian Journal of Surgery|February 21, 2019
Histologic severity of liver cirrhosis: A key factor affecting surgical outcomes of hepatocellular carcinoma in patients with portal hypertensionKe-Shuai Dong, Bin-Yong Liang, Zun-Yi Zhang, et al.
Pageof 4